Reason Lilly Stock Still: A Buy Case for 2026 and Beyond
Lilly stock has faced pressure, but one key driver could keep it in buy territory. This article unpacks the core reas...
What Credit Card Has The Best Rewards Program
Explore the credit cards with the best rewards programs to maximize your benefits and savings. Find your perfect match.
26,855 articles
Strategy Posts $12.5B Loss as Bitcoin Dips in Q1 2026
Strategy reported a $12.54 billion Q1 loss driven by unrealized BTC declines, even as its software business expanded ...
Is Chevron Safe Energy Sector? A New Look at Oil Giant Path
Chevron reports stronger-than-expected Q1 2026 results and advancing Hess synergy-driven production, but investors de...
Trump Promised Refill America’s Oil Reserve, but It Drained
The Strategic Petroleum Reserve posted what may be its largest weekly withdrawal, about 10 million barrels, pushing s...
U.S. Iran Appear From Peace Talks Falter After 100 Days
Marking 100 days since the war began, negotiators say progress remains elusive. The standoff is spilling into energy ...
Gate CrossEx: An Exchange-Native Answer to Fragmentation
Gate CrossEx rolls out an exchange-native platform designed to unify institutional capital across leading crypto venu...
Ripple (XRP) News Today: New Partnerships Drive Momentum
Ripple unveils strategic deals and a ledger upgrade to boost adoption. XRP trades around $0.65, with meaningful insti...
Rocket Lab’s Just Billion Bet on SpaceX Rivalry Stirs Markets
Rocket Lab unveiled an approximately $8 billion plan to acquire Iridium, aiming to become a full-stack space operator...
Utah Revokes License of Provo Canyon School, Cites Safety Failures
Utah regulators move to revoke the license of Provo Canyon School, citing a pattern of health and safety failures. Th...
Cramer: Cheap Still Cheaper — Salesforce Skeptics Persist
Jim Cramer remains wary of Salesforce as growth slows and CIOs shift budgets to less expensive software. He argues th...
Ionis Pharmaceuticals Drops Another After Phase 3 Setback
Ionis Pharmaceuticals dropped again after a Phase 3 failure in transthyretin amyloid cardiomyopathy, triggering a bro...
Bezos’ Blue Origin Raising Outside Capital to Compete
Blue Origin plans a $10 billion round at a $130 billion valuation, backed by Jeff Bezos and institutional investors. ...
Popular Topics
Fable
Smart Money Moves For Everyday Life
Investment Strategies In Energy Sector
Best Index Funds For Retirement
Investment Strategies
Untitled D6eff7ea
Crypto For Beginners
Best Dividend Etfs
Index
Innovative Skincare Clinical
Dutch Salary
Blue Owl
Budget
Ai Healthcare News
Penalty Vs No Penalty Depending On Lock Status